Immediate Impact
17 standout
Citing Papers
The progression of inorganic nanoparticles and natural products for inflammatory bowel disease
2024 Standout
Recent progress of CDK4/6 inhibitors’ current practice in breast cancer
2024 Standout
Works of John Waller being referenced
Real-World Treatment Patterns and Clinical Outcomes in Patients Receiving Palbociclib for Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced or Metastatic Breast Cancer in Argentina: The IRIS Study
2019
Treatment patterns and clinical outcomes among patients receiving palbociclib in combination with an aromatase inhibitor or fulvestrant for HR+/HER2-negative advanced/metastatic breast cancer in real-world settings in the US: Results from the IRIS study
2018
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| John Waller | 73 | 101 | 34 | 112 | 107 | 38 | 399 | |
| Lee Mozessohn | 64 | 29 | 4 | 63 | 87 | 48 | 341 | |
| Didier Mayeur | 26 | 119 | 21 | 27 | 199 | 51 | 371 | |
| Lee Chun Park | 38 | 94 | 3 | 43 | 109 | 30 | 360 | |
| Manal O. Elnenaei | 69 | 51 | 28 | 87 | 121 | 32 | 447 | |
| Oluwakayode Adejoro | 76 | 164 | 6 | 44 | 86 | 33 | 412 | |
| Jerzy S. Tarach | 54 | 14 | 33 | 87 | 22 | 36 | 384 | |
| Syed Ziauddin A. Zaidi | 119 | 16 | 41 | 46 | 39 | 38 | 405 | |
| Sarah S. Burns | 71 | 36 | 8 | 53 | 81 | 28 | 457 | |
| Jane Jijun Liu | 66 | 25 | 9 | 64 | 167 | 23 | 379 | |
| Carrie Ye | 10 | 52 | 10 | 44 | 238 | 43 | 361 |
All Works
Login with ORCID to disown or claim papers
Loading papers...